— Know what they know.
Not Investment Advice

CTOR NASDAQ

Citius Oncology, Inc.
1W: -9.5% 1M: +22.2% 3M: +34.0% YTD: -12.0% 1Y: -51.8%
$0.95
-0.03 (-3.06%)
 
Weekly Expected Move ±13.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 58 · $88.3M mcap · 18M float · 0.489% daily turnover · Short 35% of daily vol

Balance Sheet Trends

Total Assets
$101M +19.6% ▲
3Y CAGR: +33.2%
Total Liabilities
$56M +46.7% ▲
3Y CAGR: +105.9%
Shareholders Equity
$45M -2.8% ▼
3Y CAGR: +7.3%
Cash & Investments
$4M +3504282.1% ▲
Total Debt
$4M +0.0% ▲
Net Debt
-$125K -103.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$289K$27K$112$4M
Short-Term Investments$0$0$0$0
Cash & ST Investments$0$0$112$4M
Net Receivables$0$0$0$0
Inventory$0$0$8M$22M
Other Current Assets$0$0$0$0
Total Current Assets$3M$8M$11M$28M
Property, Plant & Equip.$0$0$0$0
Goodwill & Intangibles$40M$40M$73M$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0$0$0$73M
Total Non-Current Assets$40M$40M$73M$73M
Total Assets$43M$48M$84M$101M
— Liabilities —
Accounts Payable$92K$1M$4M$13M
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$0
Other Current Liabilities$0$0-$589K$23M
Total Current Liabilities$6M$21M$33M$49M
Long-Term Debt$0$0$4M$4M
Other Non-Current Liab.$0$0$0$3M
Total Non-Current Liabilities$576K$1M$6M$7M
Total Liabilities$6M$22M$38M$56M
— Equity —
Common Stock$7K$7K$7K$8K
Retained Earnings-$5M-$18M-$39M-$64M
Accumulated OCI$0$0$0$0
Total Stockholders Equity$36M$26M$46M$45M
Total Liabilities & Equity$43M$48M$84M$101M
— Key Metrics —
Total Debt$0$0$4M$4M
Net Debt-$289K-$27K$4M-$125K
Total Investments$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms